Thermo Fisher Scientific Inc

Stock Chart, Company Information, and Scan Results

$482.03(as of Jun 4, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Thermo Fisher Scientific Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$482.03
Ticker SymbolTMO
ExchangeNyse
SectorHealthcare
IndustryDiagnostics & Research
Employees125,000
CountyUSA
Market Cap$176,130M
EBIDTA11,296.0M
10-Day Moving Average471.39
P/E Ratio26.21
20-Day Moving Average461.97
Forward P/E Ratio19.01
50-Day Moving Average479.99
Earnings per Share18.20
200-Day Moving Average526.12
Profit Margin15.00%
RSI55.29
Shares Outstanding371.6M
ATR14.80
52-Week High643.35
Volume2,146,641
52-Week Low384.44
Most Recent Support Level469.11
Book Value51,940.0M
Most Recent Resistance Level499.00
P/B Ratio3.46
Upper Keltner495.27
P/S Ratio3.98
Lower Keltner428.67
Debt-to-Equity Ratio495.27
Next Earnings Date07/21/2026
Cash Surplus-11,367.0M
Next Ex-Dividend Date06/15/2026

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc In Our Stock Scanner

As of Jun 05, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.